Rankings
▼
Calendar
BVS FY 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
FY 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$568M
-0.9% YoY
Gross Profit
$382M
67.3% margin
Operating Income
$59M
10.3% margin
Net Income
$23M
4.0% margin
EPS (Diluted)
$0.33
Cash Flow
Operating Cash Flow
$74M
Free Cash Flow
$71M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$684M
Total Liabilities
$455M
Stockholders' Equity
$184M
Cash & Equivalents
$51M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$568M
$573M
-0.9%
Gross Profit
$382M
$388M
-1.5%
Operating Income
$59M
-$12M
+588.7%
Net Income
$23M
-$34M
+167.8%
← Q4 2024
All Quarters
Q1 2025 →